Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000503806 | SCV000597798 | likely pathogenic | Tyrosinase-negative oculocutaneous albinism | 2016-03-31 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000762871 | SCV000893251 | pathogenic | Tyrosinase-negative oculocutaneous albinism; Oculocutaneous albinism type 1B; Ocular albinism with congenital sensorineural hearing loss; SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000085908 | SCV001782045 | pathogenic | not provided | 2020-10-19 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 31199599, 19865097, 26165494, 31196117, 29658579, 22875490, 29437493, 20447099, 31229681, 25577957, 31077556, 10571953, 16570240, 22097729, 15591842, 30868138) |
Genome- |
RCV000503806 | SCV001821966 | likely pathogenic | Tyrosinase-negative oculocutaneous albinism | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000085908 | SCV003441031 | pathogenic | not provided | 2024-11-18 | criteria provided, single submitter | clinical testing | This sequence change replaces tryptophan, which is neutral and slightly polar, with leucine, which is neutral and non-polar, at codon 400 of the TYR protein (p.Trp400Leu). This variant is present in population databases (rs62645916, gnomAD 0.05%). This missense change has been observed in individuals with non-syndromic ocular albinism (PMID: 31077556). ClinVar contains an entry for this variant (Variation ID: 99541). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt TYR protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003460776 | SCV004207565 | pathogenic | SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN | 2024-03-27 | criteria provided, single submitter | clinical testing | |
Juno Genomics, |
RCV004796012 | SCV005418445 | pathogenic | Tyrosinase-negative oculocutaneous albinism; Oculocutaneous albinism type 1B | criteria provided, single submitter | clinical testing | PM3_VeryStrong+PP4+PM2_Supporting+PP3_Strong | |
Fulgent Genetics, |
RCV005008002 | SCV005631382 | pathogenic | Tyrosinase-negative oculocutaneous albinism; Oculocutaneous albinism type 1B; SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Retina International | RCV000085908 | SCV000118051 | not provided | not provided | no assertion provided | not provided | ||
Prevention |
RCV004739347 | SCV005360272 | pathogenic | TYR-related disorder | 2024-07-30 | no assertion criteria provided | clinical testing | The TYR c.1199G>T variant is predicted to result in the amino acid substitution p.Trp400Leu. This variant has been reported as causative for autosomal recessive oculocutaneous albinism (Tsai et al. 1999. PubMed ID: 10571953; Liu et al. 2010. PubMed ID: 20447099; Wei et al. 2010. PubMed ID: 19865097; Zhong et al. 2019. PubMed ID: 31077556). This variant is reported in 0.050% of alleles in individuals of East Asian descent in gnomAD. Given the evidence, we interpret this variant as pathogenic. |